Granisetron (Intravenous Route)
Name: Granisetron (Intravenous Route)
- Granisetron Intravenous Route dosage
- Granisetron Intravenous Route dosage forms
- Granisetron Intravenous Route injection
Descriptions
Granisetron injection is used to prevent nausea and vomiting that may occur after treatment with cancer medicines (chemotherapy or radiation), including high-dose cisplatin. This medicine is also used to prevent and treat nausea and vomiting that may happen after surgery.
Granisetron is a selective 5-HT3 receptor antagonist. It works in the stomach to block the signals to the brain that cause nausea and vomiting.
This medicine is to be given only by or under the immediate supervision of your doctor.
This product is available in the following dosage forms:
- Solution
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of granisetron injection in children with cancer. However, safety and efficacy have not been established in children younger than 2 years of age.
Appropriate studies have not been performed on the relationship of age to the effects granisetron injection for the prevention and treatment of nausea and vomiting after surgery in the pediatric population. Safety and efficacy have not been established.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.